The Phosphodiesterase Inhibitor Cilostazol Induces Regression of Carotid Atherosclerosis in Subjects With Type 2 Diabetes Mellitus Principal Results of the Diabetic Atherosclerosis Prevention by Cilostazol (DAPC) Study: A Randomized Trial

✍ Scribed by N. Katakami; Y.-S. Kim; R. Kawamori

• Book ID: 119316338
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 83 KB
• Volume: 52
• Category: Article
• ISSN: 1097-6809
• DOI: 10.1016/j.jvs.2010.09.047